Novavax Inc.’s recent filing unveils that its President, R&D Glenn Gregory M acquired Company’s shares for reported $6500.0 on Mar 10. In the deal valued at $6.50 per share,1,000 shares were bought. As a result of this transaction, Glenn Gregory M now holds 14,473 shares worth roughly $ 0.12 million.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Then, Glenn Gregory M bought 2,000 shares, generating $14,088 in total proceeds. Upon buying the shares at $7.04, the President, R&D now owns 13,473 shares.
Before that, Glenn Gregory M bought 3,000 shares. Novavax Inc. shares valued at $22,454 were divested by the President, R&D at a price of $7.48 per share. As a result of the transaction, Glenn Gregory M now holds 11,473 shares, worth roughly $94193.33000000002.
B. Riley Securities upgraded its Novavax Inc. [NVAX] rating to a Buy from a a Neutral in a research note published on Friday. PT values the company’s stock at a premium of 45.27 to its Friday closing price.
Price Performance Review of NVAX
On Friday, Novavax Inc. [NASDAQ:NVAX] saw its stock jump 2.63% to $8.21. On the same session, the stock had its day’s lowest price of $8.02, but rose to a high of $8.465. Over the last five days, the stock has gained 1.99%. Novavax Inc. shares have fallen nearly -20.14% since the year began. Nevertheless, the stocks have fallen -75.15% over the past one year. While a 52-week high of $33.37 was reached on 01/18/23, a 52-week low of $5.61 was recorded on 03/23/23. SMA at 50 days reached $7.97, while 200 days put it at $9.50. A total of 7.98 million shares were traded, compared to the trading of 7.64 million shares in the previous session.
Levels Of Support And Resistance For NVAX Stock
The 24-hour chart illustrates a support level at 8.00, which if violated will result in even more drops to 7.79. On the upside, there is a resistance level at 8.44. A further resistance level may holdings at 8.68. The Relative Strength Index (RSI) on the 14-day chart is 52.01, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.15, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 53.05%. Stochastics %K at 46.18% indicates the stock is a holding.
How much short interest is there in Novavax Inc.?
A steep rise in short interest was recorded in Novavax Inc. stocks on Aug 14, 2023, growing by 3.11 million shares to a total of 39.8 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 36.69 million shares. There was a rise of 7.81%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 49.12% of the overall stock float, the days-to-cover ratio (short ratio) rose to 5.94.
Novavax Inc. [NVAX] – Who Are The Largest Shareholders?
In filings from SSgA Funds Management, Inc., it is revealed that the company now owns 11,679,428 shares, or roughly 13.53% of the outstanding NVAX shares. In other words, the investor’s shares have risen by 576,803 from its previous 13-F filing of 11102625.0. Additionally, The Vanguard Group, Inc. increased 2.56% of its stake after which the total value it holdings stand at $95,917,440, while BlackRock Fund Advisors added 54.73% of its stake to hold $55.2 million in the firm. Over the last quarter, Shah Capital Management, Inc. purchased 1,229,680 shares of Novavax Inc., while BofA Securities, Inc. bought 529,211 shares. At present, Morgan Stanley & Co. LLC is holding 1,839,734 shares valued at $17.07 million. Geode Capital Management LLC owned 1,743,006 shares of the company at the time of its most recent 13F filing, worth $16.18 million.
According to FactSet, Novavax Inc.’s share price will average $20.60 in the next year, based on opinions of analysts polled by the firm. This is up nearly 87.5 percent from its previous closing price of $8.00. Analysts expect Novavax Inc. stock to reach the higher price of $38.00, while the lowest price estimate is $5.00. However, 6 analysts have rated NVAX stock as a Hold in their predictions for 2023.